GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Shanghai Pioneer Holding Ltd (HKSE:01345) » Definitions » 3-Year Book Growth Rate

Shanghai Pioneer Holding (HKSE:01345) 3-Year Book Growth Rate : 0.80% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Shanghai Pioneer Holding 3-Year Book Growth Rate?

Shanghai Pioneer Holding's Book Value per Share for the quarter that ended in Dec. 2023 was HK$0.88.

During the past 12 months, Shanghai Pioneer Holding's average Book Value per Share Growth Rate was -2.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was 0.80% per year. During the past 5 years, the average Book Value per Share Growth Rate was -2.50% per year. During the past 10 years, the average Book Value per Share Growth Rate was -1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 12 years, the highest 3-Year average Book Value per Share Growth Rate of Shanghai Pioneer Holding was 65.70% per year. The lowest was -5.80% per year. And the median was -1.20% per year.


Competitive Comparison of Shanghai Pioneer Holding's 3-Year Book Growth Rate

For the Pharmaceutical Retailers subindustry, Shanghai Pioneer Holding's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pioneer Holding's 3-Year Book Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Shanghai Pioneer Holding's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Pioneer Holding's 3-Year Book Growth Rate falls into.



Shanghai Pioneer Holding 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Shanghai Pioneer Holding  (HKSE:01345) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Shanghai Pioneer Holding 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Pioneer Holding's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pioneer Holding (HKSE:01345) Business Description

Traded in Other Exchanges
N/A
Address
No.15, Lane 88 Wuwei Road, Putuo District, Shanghai, CHN, 200331
Shanghai Pioneer Holding Ltd is an investment holding company. It is engaged in the marketing, promotion, sales, and channel management service for pharmaceutical products and medical devices in China. The company has a portfolio of pharmaceutical products, covering ophthalmology, pain management, cardiovascular, gastroenterology, immunology, gynecology, and other therapeutic areas, and medical devices covering several medical specialties, including ophthalmology, orthopedics, odontology, and wound care. The majority of its revenue derives from the Sales of pharmaceutical products segment. The group operates mainly in PRC.

Shanghai Pioneer Holding (HKSE:01345) Headlines

No Headlines